Home · Stocks · Pharmala Biotech Holdings-stock · News for Pharmala Biotech Holdings · PharmAla to supply STRONG STAR at UT Health San Antonio, with novel ...
News
- PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of ...
- Gregg Popovich says he will not return to the Spurs this season - The Boston Globe
The 76-year-old met with San Antonio management Thursday, and he and the team released a statement afterward about his status.
- PharmAla Advances MDMA Trial for Military PTSD Treatment - TipRanks.com
PharmAla Biotech Holdings Inc. has announced the progression of its contract with the University of Texas Health Science Center at San Antonio, funded ...
- Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
(Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 ... Presented two posters at the San Antonio Breast Cancer Symposium.
- PharmAla Develops New MDMA Dosage for $10M DoD-Funded PTSD Study in Military Personnel
PharmAla Biotech Holdings (OTC:MDXXF) has announced advancement of its contract with UT Health San Antonio for the STRONG STAR Consortium study, ...